.Merck beats incomes requirements, brings up sales expectation on solid need for best drugs like Keytruda CNBCMerck & Co. (MRK US) Trumps Revenue Forecasts as Keytruda Purchases Rise BloombergMerck Supply: Pharma Giant Posts Powerful End Results, Yet Outlook Tumbles Short Real estate investor's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats income as well as sales desires in the middle of Keytruda asset, but delivers combined full-year expectation MarketWatch.